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Abstract: A practical protocol for the preparation of (5Z)-2-alkylthio-5-arylmethylene-1-
methyl-1,5-dihydro-4H-imidazol-4-one derivatives is reported. The new compounds were 
obtained in good yield and stereoselectivity in two steps, namely a solvent-free 
Knoevenagel condensation under microwave irradiation, followed by an S-alkylation 
reaction with various halogenoalkanes. 
Keywords: 1,5-dihydro-4H-imidazol-4one; Knoevenagel condensation; microwave 
irradiation; S-alkylation 
 
1. Introduction 
2-Thiohydantoins (4-oxoimidazolidine-2-thiones) [1,2] and their 2-alkylthio-3,5-dihydro-4H-
imidazol-4-one derivatives are a biologically important class of compounds in the fields of drugs, 
pharmaceutical intermediates and agrochemicals. As examples, the isatinylidene derivative I (Figure 1) 
exhibits immunosuppressive activity [3] and the thioglycosyl hydantoin [4] II possesses a broad 
spectrum antitumor activity against a wide range of different human cell lines from nine tumor 
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subpanels causing both cytostatic and cytotoxic effects. The 5-arylmethylene-2-methylthio-imidazol-4-
ones III substituted with a biphenyltetrazole (BTP) group at the C-2 position show activities as 
angiotensin II receptor antagonists [5] and the 3-morpholinomethyl-5,5-dimethyl-2-thioglycosyl-
imidazol-4-one IV has been also identified as a potential AZT analogue [6]. The 2-thiohydantoin 
derivatives have not only been used in medicinal chemistry, but have also been developed as 
fungicides [7] [e.g., fenamidone (V) [8,9]] and herbicides [10]. Recent work [11] by Wang's group has 
established that esters of 5-(4-hydroxybenzyl)thiohydantoins exhibit good herbicidal activity against 
Zea mays and Arabidopsis thaliana. 
Figure 1. Select 3,5-dihydro-4H-imidazol-4-one derivatives with biological activities. 
N
NMeS
HN
O
Me
O
AcO
AcO
OAc
S
OAc
N
N
O
S
Br
O
AcO
AcO
OAc
S
OAc
N
N
O
Me
Me
N
O
N
N
O
R2S
R1
R2S
N
N
O
N
R1
O
I II
S
N
N
O
III: (R = Me, Et)
R
R
N
NH
NN
IV
V VI
Ar
 
On the other hand, the synthesis and biological properties of 2-alkylthio-5-arylmethylene-1,5-
dihydro-4H-imidazol-4-one derivatives VI have rarely been the subject of detailed investigations 
reported in the literature. A 17-year-old study of Unangst and co-workers only reported the preparation 
of (5Z)-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methylene]-1,5-dihydro-1-methyl-2-methylthio-
4H-imidazol-4-one for an inflammation therapy program [12]. In 1993, a report described the 
biological activity of the same compound as a potent antiviral agent for the human immunodeficiency 
virus (HIV) [13]. More recently, the use of 5-arylidene-1-methyl-1,5-dihydro-4H-imidazol-4-one as  
a convenient synthetic intermediate in a sulfur/nitrogen displacement has been studied with one 
example [14]. 
Due to the biological activity associated with the imidazolone moiety, we embarked on a project to 
investigate possible bioactive molecules based on 2-alkylthio-5-arylmethylene-1-methyl-1,5-dihydro-
4H-imidazol-4-one derivatives of the imidazolone core. Herein, we report our results concerning the 
synthesis of these new 2-alkylthio-5-arylmethylene derivatives based on the 1-methyl-2-thiohydantoin 
scaffold and their biological evaluation as protein kinase inhibitors. The protein kinases of the human 
kinome represent a wide family of disease relevant targets for identification, preparation and 
optimization of potential therapeutic agents in structure-activity relationship (SAR) studies [15]. 
2. Results and Discussion 
Most of the 2-alkylthio-5-arylmethylene imidazol-4-ones syntheses described in the literature 
involve: (i) a Knoevenagel condensation of an aryl/heteroaryl aldehyde with a 2-thiohydantoin 
followed by a regioselective S-alkylation [16] or (ii) reaction of vinylisothiocyanate [17] (obtained 
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from an iminophosphorane [18] and carbon disulfide) with a primary amine giving the  
5-arylmethylene-2-thioxo-imidazol-4-one structure [19,20], which is then converted into the S-alkyl 
derivative by the action of an alkylating reagent. 
For this project, the needed 2-alkylthio-5-arylmethylene-1-methyl-1,5-dihydro-4H-imidazol-4-one 
can be built from sarcosine and a thiocyanate as precursors of the 1-methyl-2-thiohydantoin scaffold, 
aldehydes and halogenoalkanes, to introduce diversity at the C-5 position and on the sulfur atom at the 
C-2 position respectively, by Knoevenagel condensation and S-alkylation reactions (Figure 2). 
Figure 2. Components used for the synthesis of 2-alkylthio-5-arylmethylene-1-methyl-1,5-
dihydro-4H-imidazol-4-ones. 
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As illustrated in Scheme 1, the synthesis started with the preparation of 1-methyl-2-thiohydantoin 
(1) from commercially available sarcosine and ammonium thiocyanate.  
Scheme 1. Route used for the synthesis of 2-alkylthio-5-arylmethylene-1-methyl-1,5-
dihydro-4H-imidazol-4-ones. 
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Reagent and reaction conditions: (i) NH4SCN (3 equiv.), 140 °C, 19 h. (ii) Method A: 2 (1 equiv.), 
propylamine (2 equiv.), PZ, 80 °C, 40-60 min. or Method B: 3 (1 equiv.), PZ, 80 °C, 40-60 min. 
(iii) 5 (1-1.5 equiv.), K2CO3 (0.5 equiv.), KI (1 equiv.), MeCN, 60-81 °C, 19-51 h. 
Complete conversion according to the modified procedure of Kenyon et al. [21,22] was observed 
after 19 hours at 140 °C, affording the desired starting compound 1 in 90% yield. In the second step, 
for the Knoevenagel condensations from aryl aldehydes and thiohydantoins, several methods have 
been employed in the literature. Many of these methods suffer from one or more limitations such as 
requiring harsh reaction conditions, producing low to moderate yields, relatively long reaction times 
and cumbersome experimental processes. Among these reported methods, the Knoevenagel reaction 
has been performed in the presence of mineral or organic bases with various solvents: ethanolamine in 
absolute ethanol [23], potassium hydroxide in anhydrous ethanol [24], sodium hydride in anhydrous 
acetonitrile [25]. The utility of microwave irradiation (PZ) to carry out organic reaction has now 
become a regular feature. The main benefits of performing the reaction under microwave conditions 
are the higher product yields and the significant rate-enhancements that can be observed. It’s clear that 
Molecules 2011, 16                            
 
 
7380
application of microwave technology to the rapid synthesis of potential biological molecules is a useful 
tool for the medicinal chemistry community, for whom reaction speed is of great importance [26,27]. 
Moreover, when a reaction is carried out in a microwave reactor, the use of solvent can be  
avoided [28,29], allowing eco-friendly synthesis and offering several advantages, such as reduced risk of 
explosions and easier work-up. In this context, we have examined two experimental protocols for the 
synthesis of 5-arylmethylene-1-methyl-2-thiohydantoins 4. 
The results of the two methods investigated for the preparation of Knoevenagel products 4 are 
presented in Table 1. In Method A, 1-methyl-2-thiohydantoin (1) was coupled with commercial aryl 
aldehydes 2(a-e) in the presence of two equivalents of propylamine at 80 °C under microwave 
irradiation (in a Synthewave® 402 reactor [30]) for a reaction time ranging from 40 to 60 minutes. In 
Method B, an equimolecular mixture of the starting hydantoin 1 and arylaldimine 3 was heated at  
80 °C under microwave irradiation for the same reaction time. The arylaldimines 3 were prepared in 
good yields according to a solvent-free microwave protocol developed in our laboratory [31]. The 
reactions of both methods were conveniently monitored by 1H- NMR or by TLC on precoated plates of 
silica gel with an appropriate eluant. As can be seen from inspection of the data presented in Table 1, 
the 5-arylmethylene-1-methyl- 2-thioxo-imidazolidin-4-ones 4(a-e) were prepared in better yields  
(86-98%) using the microwave irradiation reaction conditions (Method A). It is noteworthy that for 
safety reasons, a 4-min. heating ramp was performed before the temperature was maintained at the 
selected maximum of 80 °C (power 80 W). The structure of the new compounds 4(a-e) were 
substantiated by 1H-, 13C-NMR and HRMS. In all cases, compounds 4 were obtained in a 
stereospecific way and the geometry of the double bond was attributed as being Z by the shielding 
effect of the carbonyl group C-4 on the olefinic proton H-5 (GH-5 = 6.34-6.85 ppm) [32,33]. 
Table 1. Results for the solvent-less preparation of 5-arylmethylene-1-methyl-2-thioxo 
imidazolin-4-ones 4(a-e) under microwave from aldehydes 2(a-e) (Method A) or aldimines 
3(a-e) (Method B). 
Product 
Method A Method B 
Starting reagent Yield 
a
 of 4 (%) Starting reagent Yield 
a
 of 4 (%) 
4a 2a 96 3a 88 
4b 2b 96 3b 92 
4c 2c 90 3c 90 
4d 2d 86 3d -b 
4e 2e 98 3e 92 
O
O
O
2a
O
O
2c
O
O
HO
O
2d
O
O
O
2b
O
O
O
2e
a Yield of isolated product after purification by recrystallization; b The reaction failed under 
microwave and also in an oil bath using the same reaction conditions. 
With the 5-arylmethylene-1-methyl-2-thioxo imidazolin-4-one derivatives 4 in hand, we designed 
an experimental strategy for the preparation of the 2-alkylthio-1,5-dihydro-4H-imidazol-4-ones 6. For 
this study, a set of different halogeno compounds 5 represents the second point of diversity in this 
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scaffold by using commercial products [ethyl iodide (5a), allyl bromide (5b), propyl bromide (5c), 
chloroacetonitrile (5d), ethyl bromoacetate (5e) and 3-bromopropanol (5f)]. Owing to the lesser 
reactivity of the chloro and bromo alkanes 5(b-f), one equivalent of potassium iodide was added in the 
reaction mixtures and the reagents were covered with dry acetonitrile. After work-up (elimination of 
the salts and solvent), all the crude products were purified easily by recrystallization in ethanol. The 
reaction conditions listed in Table 2 showed that the S-alkylations could be carried out at various 
reaction temperatures (60-81 °C) with a reaction time ranging from 14 to 51 hours. As seen from the 
results, it can be observed that these S-alkylations gave moderate to good yields (42-68%). The 
structural assignment of the new 2-alkylthio-5-arylmethylene-1-methyl 1,5-dihydro-4H-imidazol-4-
ones 6(a-g) is based on spectroscopic data (1H-, 13C-NMR, HRMS). It should be noted that  
this alkylation step gave regioselective S-alkylation with retention of the (5Z)-stereochemistry  
(GH-5 = 6.83-7.21 ppm). 
The (5Z) 2-alkylthio-5-arylmethylene-1-methyl-1,5-dihydro-4H-imidazol-4-ones 6(a-g) were next 
tested for their potential inhibitory action on two protein kinases, CDK1/cyclin B and GSK-3D/E. 
Kinases were purified and essayed in the presence of 15 mM ATP and appropriate protein substrates 
(histone H1 for CDK1/cyclin B, GS-1 peptide for GSK-3D/E) as previously described [34-36]. 
Investigation of in-vitro bioactivity revealed that none of the compounds 6(a-g) was active  
(IC50 > 10 PM). 
Table 2. Results for the preparation of (5Z)-2-alkylthio-5-arylmethylene-1-methyl 1,5-
dihydro-4H-imidazol-4-one 6(a-e) from (5Z)-5-arylmethylene-1-methyl-2-thioxo imidazol-
in-4-ones 4 and halogeno alkanes 5. 
Product 6 R 
Starting 
product 4 
Reagent 5 
Reaction 
conditions: 
temperature 
a
 
and reaction time 
Yield 
b
 
of 6 (%) 
6a CH3CH2 4a 5a 60 °C, 51 h 60 
6b CH2=CH-CH2 4a 5b 66 °C, 48 h 65 
6c CH3CH2CH2 4a 5c 65 °C, 24 h 62 
6d NC-CH2 4a 5d 81 °C, 19h 66 
6e EtO2C-CH2 4a 5e 60 °C, 14 h 68 
6f EtO2C-CH2 4b 5e 60 °C, 19 h 62 
6g HOCH2CH2CH2 4a 5f 70 °C, 46 h 42 
I
5a
Br
5b
Br
5c
Cl
N
5d
O
Br
O
5e
HO Br
5f  
a Reactions were run in a thermostated oil bath, temperature variation ±1 °C; b Yield of isolated 
product after purification by recrystallization. 
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3. Experimental  
3.1. General  
Melting points were determined on a Kofler melting point apparatus and are uncorrected.  
Thin-layer chromatography (TLC) was accomplished on 0.2-mm precoated plates of silica gel 60  
F-254 (Merck) and visualization was made with ultraviolet light (254 and 312 nm) or with a 
fluorescent indicator. 1H- and 13C-NMR spectra were recorded on a Bruker AC 300 P spectrometer at 
300 MHz and 75 MHz, respectively. Chemical shifts are expressed in parts per million downfield from 
tetramethylsilane as an internal standard. Data are given in the following order: d value, multiplicity (s, 
singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad), number of protons, coupling constants 
J is given in Hertz. The mass spectra (HRMS) were taken respectively on a Varian MAT 311 at an 
ionizing potential of 70 eV in the Centre Régional de Mesures Physiques de l’Ouest (CRMPO, 
Rennes, France). Reactions under microwave irradiations were realized in the Synthewave® 402 
apparatus (Merck Eurolab, Div. Prolabo, France). The microwave instrument consists of a continuous 
focused microwave power output from 0 to 300W. All the experiments were performed using stirring 
option. The target temperature was reached with a ramp of 4 minutes and the chosen microwave power 
stay constant to hold the mixture at this temperature. The reaction temperature is monitored using 
calibrated infrared sensor and the reaction time includes the ramp period. Acetonitrile was distilled 
over calcium chloride after standing overnight and stored over molecular sieves (3Å). Solvents were 
evaporated with a Büchi rotary evaporator. All reagents were purchased from Acros, Aldrich Chimie, 
Fluka France and used without further purification. 
1-Methyl-2-thioxo imidazolidin-4-one (1): This starting compound was prepared in a 50 mL two-
necked round-bottomed flask, equipped with a magnetic stirrer and reflux condenser by the fusion of 
commercial sarcosine (4 g, 44.9 mmol) with ammonium thiocyanate NH4SCN (10.26 g, 134.7 mmol,  
3 equiv.) at 140 °C under a slow stream of nitrogen. After 19 hr of heating under vigorous stirring, the 
dark red solution was cooled. The solid cake which formed was broken up and washed with 20 mL of 
water onto a filter. The crystals were then washed successively with deionized water (three 15 mL 
portions), 95% ethanol (one 20 mL portion) and hexane (one 20 mL portion). The precipitated product 
was further dried under high vacuum (10í2 Torr) at 30 °C for 2 hours, to give the desired 1-methyl-2-
thioxoimidazolidin-4-one (1) as a powder that was used without further purification. Yield = 90%.  
Mp = 230-232 °C. 1H-NMR [(CD3)2SO] G= 3.12 (s, 3H, NCH3); 4.20 (s, 2H, CH2); 11.67 (br s, 1H, 
NH). 13C-NMR [(CD3)2SO] G= 33.3 (NCH3); 55.7 (CH2, C-5); 172.7 (C=O, C-4); 182.0 (C=S, C-2). 
HRMS, m/z found: 130.0207 (calculated for C4H6N2OS, M
+. requires: 130.0201). 
3.2. General Procedure for the Solventless Synthesis of (5Z) 5-Arylmethylene-1-methyl-2-thioxo-
imidazolin-4-ones 4 under Microwave Dielectric Heating according to Method A and Method B: 
Method A: A mixture of 1-methyl-2-thioxo-imidazolidin-4-one (1, 1.3 g, 10 mmol), propylamine  
(1.64 mL, 20 mmol, 2 equiv.) and appropriate aromatic aldehyde 2 (10 mmol) was placed in a 
cylindrical quartz reactor (Ø = 2.8 cm). The reactor was then introduced into a Synthewave® 402 
Prolabo microwave reactor (P = 300 Watt). The stirred mixture was irradiated at 80 °C (with a power 
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of 90 Watt) for 40-60 min. After microwave dielectric heating, the crude reaction mixture was allowed 
to cool down at room temperature and was concentrated by rotary evaporation under reduced pressure. 
Ethanol (10 mL) was added directly in the crude reaction mixture and the resulting precipitated crude 
product 4 was filtered off and purified by recrystallization from ethanol to give the desired (5Z)  
5-arylmethylene-1-methyl-2-thioxo-imidazolin-4-one 4. 
Method B: A mixture of 1-methyl-2-thioxo-imidazolidin-4-one (1, 1.3 g, 10 mmol) and an appropriate 
aldimine 3 (10 mmol) was placed in a cylindrical quartz reactor (Ø = 2.8 cm). The reactor was then 
introduced into a Synthewave® 402 Prolabo microwave reactor (P = 300 Watt). The stirred mixture 
was irradiated at 80 °C (with a power of 90 Watt) for 40-60 min. After microwave dielectric heating, 
the crude reaction mixture was allowed to cool down at room temperature and was concentrated by 
rotary evaporation under reduced pressure. Ethanol (10 mL) was added directly in the crude reaction 
mixture and the resulting precipitated crude product 4 was filtered off and purified by recrystallization 
from ethanol to give the desired (5Z) 5-arylmethylene-1-methyl-2-thioxo-imidazolin-4-one 4. 
(5Z)-5-(1,3-Benzodioxol-5-ylmethylene)-1-methyl-2-thioxoimidazolidin-4-one (4a): Method A: The 
product 4a was prepared from 1 (1.3 g, 10 mmol), propylamine (1.64 mL, 20 mmol, 2 equiv.) and 
piperonal (2a, 1.502 g, 10 mmol) with a reaction of 50 min. Yield = 96%. 
Method B: The product 4a was prepared from 1 (650 mg, 5 mmol) and N-(1,3-benzodioxol-5-
ylmethylene)propan-1-amine (3a, 630 mg, 5 mmol) with a reaction time 60 min. Yield = 88%. 
Yellow needles, mp = 252-254 °C. 1H-NMR [(CD3)2SO] G= 3.18 (s, 3H, NCH3); 6.09 (s, 2H, 
OCH2O); 6.54 (s, 1H, C=CH); 6.96 (d, 1H, J = 8.1 Hz, H-5', Ar); 7.27 (d, 1H, J = 8.1 Hz, H-6', Ar); 
7.45 (s, 1H, H-2', Ar); 12.22 (br s, 1H, NH). 13C-NMR [(CD3)2SO] G= 27.6 (NCH3); 102.10 (OCH2O); 
109.10 (C-5); 109.81 (C-2); 113.70 (C=CH); 125.11 (C=CH); 126.90 (C-6); 126.91 (C-1); 148.40  
(C-4); 149.02 (C-3); 164.61 (C=O); 179.0 (C=S). HRMS, m/z found: 262.0409 (calculated for 
C12H10N2O3S, M
+. requires: 262.0412). 
(5Z)-5-(3,4-Dimethoxybenzylidene)-1-methyl-2-thioxoimidazolidin-4-one (4b): Method A: The product 
4b was prepared from 1 (1.3 g, 10 mmol), propylamine (1.64 mL, 20 mmol, 2 equiv.) and 3,4-
dimethoxybenzaldehyde (2b, 1.670 g, 10 mmol) with a reaction time of 40 min. Yield= 96%. 
Method B: The product 4b was prepared from 1 (1 g, 6.57 mmol) and N-[(3,4-dimethoxyphenyl)-
methylene]propan-1-amine (3b, 1.12 mL, 13.14 mmol, 2 equiv.) with a reaction time 60 min.  
Yield = 92%. 
Yellow needles, mp= 234-236 °C. 1H-NMR [(CD3)2SO] G= 3.12 (s, 3H, NCH3); 3.92 (s, 3H, 
OCH3); 3.93 (s, 3H, OCH3); 6.44 (d, 1H, J = 8.8 Hz, H-5', Ar); 6.81 (s, 1H, C=CH); 7.24 (d, 1H,  
J = 6.4 Hz, H-6', Ar); 7.25 (s, 1H, H-2, Ar); 12.08 (br s, 1H, NH). 13C-NMR [(CD3)2SO] G= 25.02 
(NCH3); 55.51 (OCH3); 55.91 (OCH3); 113.82 (C-5); 114.53 (C-2); 116.20 (C=CH); 124.21 (C-6); 
125.30 (C-1); 125.61 (C=CH); 148.30 (C-4); 149.11 (C-3); 166.32 (C=O); 178.80 (C=S). HRMS, m/z 
found: 278.0701 (calculated for C13H14N2O3S, M
+. requires: 278.0725). 
(5Z)-5-(3,5-Dimethoxybenzylidene)-1-methyl-2-thioxoimidazolidin-4-one (4c): Method A: The product 
4c was prepared from 1 (650 mg, 5 mmol), propylamine (1.32 mL, 10 mmol, 2 equiv.) and  
3,5-dimethoxybenzaldehyde (2c, 1.240 g, 5 mmol) with a reaction of 40 min. Yield = 90%. 
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Method B: Compound 4c was prepared from 1 (1 g, 6.57 mmol.) and N-[(3,5-dimethoxyphenyl)-
methylene]propan-1-amine (3c, 1.12 mL, 13.14 mmol, 2 equiv.) with a reaction time 60 min.  
Yield = 90%. 
Yellow needles, mp > 260 °C. 1H-NMR [(CD3)2SO] G= 3.24 (s, 3H, NCH3); 3.83 (s, 6H, OCH3); 
6.49 (s, 1H, H-4', Ar); 6.85 (s, 1H, C=CH); 7.40 (s, 2H, H-2', H-6', Ar); 12.02 (br s, 1H, NH). 13C- 
NMR [(CD3)2SO] G= 25.21 (NCH3); 55.12 (OCH3); 103.04 (C-4); 109.31 (C-2); 123.52 (C=CH); 
136.23 (C-1); 138.80 (C=CH); 160.62 (C-3); 167.31 (C=O); 178.84 (C=S). HRMS, m/z found: 
278.0630 (calculated for C13H14N2O3S, M
+. requires: 278.0725). 
(5Z)-5-(3-Hydroxy-4-methoxybenzylidene)-1-methyl-2-thioxoimidazolidin-4-one (4d): The product 4d 
was prepared from 1 (855 mg, 6.57 mmol), propylamine (1.08 mL, 13.14 mmol, 2 equiv.) and vanillin 
(2d, 1 g, 6.57 mmol) with a reaction of 60 min. according to the standard procedure for method A. 
Yield= 86%. Yellow needles, mp = 203-205 °C. 1H-NMR [(CD3)2CO] G= 3.27 (s, 3H, NCH3); 3.95 (s, 
3H, OCH3); 6.64 (s, 1H, C=CH); 6.92 (d, 1H, J = 8.7 Hz, H-5', Ar); 7.31 (d, 1H, J = 5.8 Hz, H-6', Ar); 
7.32 (s, 1H, H-2', Ar); 8.25 (br s, 1H, OH); 10.84 (br s, 1H, NH). 13C-NMR [(CD3)2CO] G= 26.70 
(NCH3); 55.62 (OCH3); 113.33 (C-2); 113.51 (C=CH); 115.61 (C-5); 124.13 (C-6); 124.70 (C=CH); 
124.84 (C-1); 147.82 (C-3); 148.53 (C-4); 16404 (C=O); 178.92 (C=S). 178.84 (C=S). HRMS, m/z 
found: 264.0552 (calculated for C12H12N2O3S, M
+. requires: 264.0569). 
(5Z)-5-(2,3-Dihydro-1,4-benzodioxan-6-ylmethylene)-1-methyl-2-thioxoimidazolidin-4-one (4e): 
Method A: The product 4e was prepared from 1 (650 mg, 5 mmol), propylamine (0.8 mL, 10 mmol,  
2 equiv.) and 1,4-benzodioxan-6-carboxaldehyde (2e, 1.540 g, 5 mmol) with a reaction of 60 min. 
Yield= 98%. 
Method B: The product 4e was prepared from 1 (1 g, 6.57 mmol) and N-[2,3-dihydro-1,4-benzo-
dioxan-6-yl)methylene]propan-1-amine (3e, 1.12 mL, 13.16 mmol, 2 equiv.) with a reaction time  
60 min. Yield= 92%. 
Yellow needles, mp > 260 °C. 1H-NMR [(CD3)2SO] G= 3.83 (s, 3H, OCH3); 4.29 (t, 2H, J = 6.8 
Hz, OCH2CH2O); 4.30 (t, 2H, J = 6.8 Hz, OCH2CH2O); 6.34 (s, 1H, C=CH); 6.78 (d, 1H, J = 8.1 Hz, 
H-5', Ar); 7.06 (d, 1H, J = 8.3 Hz, H-6', Ar); 7.10 (s, 1H, H-2', Ar); 7.82 (br s, 1H, NH). 13C-NMR 
[(CD3)2CO] G= 56.20 (OCH3); 63.81 (OCH2CH2O); 64.44 (OCH2CH2O); 110.12 (C=CH); 113.61  
(C-2); 116.23 (C-5); 124.04 (C-6); 124.62 (C-1); 126.04 (C=CH); 148.21 (C-3); 148.42 (C-4); 166.53 
(C=O); 175,.90 (C=S). HRMS, m/z found: 276.0642 (calculated for C13H12N2O3S, M
+. requires: 
276.0569). 
3.3. General Procedure for the Synthesis of Compounds 6 by S-Alkylation of 5-Arylmethylene-1-
methyl-2-thioxo imidazolin-4-ones 4(a-g) with Halogeno Compounds 5 
In a 10 mL two-necked round-bottomed flask, equipped with a magnetic stirrer and reflux 
condenser, a mixture of (5Z) 5-arylmethylene-1-methyl-2-thioxo-imidazolin-4-one 4 (10 mmoles), 
halogeno compound R-X 5 (1-1.5 equiv.), potassium carbonate (0.618 g, 5 mmoles, 0.5 equiv.) and, 
eventually potassium iodide KI (1.67 g, 10 mmoles) if X = Cl, Br for 5, in dry acetonitrile, was stirred 
vigorously at the appropriate reaction temperature (60-81 °C) for 19-51 hours. After heating was 
completed, the reaction mixture was allowed to cool down to room temperature; the solvent and the 
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volatile components were eliminated by rotary evaporation under reduced pressure. The crude residue 
was dissolved in ethyl acetate (20 mL), the contents were filtered through a sintered glass disc; the 
solution was recovered, and the solvent was removed under reduced pressure. The expected compound 
6 was purified by recrystallization in EtOH. The precipitated product 6 was filtered off and further 
dried under high vacuum (10í2 Torr) at 30 °C for 1 hour, which gave the desired (5Z)- 2-alkylthio-5-
arylmethylene-1-methyl-1,5-dihydro-imidazol-4-ones 6 as yellow solids. The pure compounds 6 were 
characterized by 1H-, 13C-NMR and HRMS. 
(5Z)-5-(1,3-Benzodioxol-5-ylmethylene)-2-ethylthio-1-methyl-1,5-dihydro-4H-imidazol-4-one (6a): 
The product 6a was prepared from (5Z)-5-(1,3-benzodioxol-5-ylmethylene)-1-methyl-2-thioxo-
imidazolidin-4-one (4a, 2.34 g, 13.2 mmol), ethyl iodide (5a, 1.45 mL, 15.9 mmol, 1.5 equiv.) and 
potassium carbonate (816 mg, 6.61 mmol, 0.5 equiv.) in acetonitrile (40 mL) with a reaction time of 51 
hours at 60 °C according to the general procedure. Yield= 60%. Yellow needles, mp > 260 °C. 1H- 
NMR [(CD3)2SO] G = 1.50 (t, 3H, J = 7.4 Hz, CH2CH3); 3.12 (s, 3H, NCH3); 3.33 (q, 2H, J = 7.4 Hz, 
SCH2); 6.00 (s, 2H, OCH2O); 6.82 (d, 1H, J = 8.1 Hz, H-5', Ar); 6.84 (s, 1H, C=CH); 7.36 (dd, 1H,  
J = 8.1, 1.0 Hz, H-6', Ar); 8.03 (s, 1H, H-2', Ar). 13C-NMR [(CD3)2CO] G = 14.71 (CH2CH3); 25.63 
(SCH2); 26.92 (NCH3); 101.82 (OCH2O); 108.84 (C-5'); 111.20 (C-2'); 124.04 (C=CH); 128.83 (C-6'); 
129.51 (C-1'); 137.52 (C=CH, C-5); 148.31 (C-4'); 149.50 (C-3'); 164.11 (C=N, C-2); 170,3 (C=O,  
C-4). HRMS, m/z found: 290.0730 (calculated for C14H14N2O3S, M
+. requires: 290.0725). 
(5Z)-2-(Allylthio)-5-[(1,3-benzodioxol-5-yl)methylene)]-1-methyl-1,5-dihydro-4H-imidazol-4-one (6b): 
The product 6b was prepared from 4a (500 mg, 1.91 mmol), potassium iodide (348 mg, 2.10 mmol, 
1.1 equiv.), 3-bromopropene (5b, 348 mg, 0,25 mL, 2.10 mmol, 1.5 equiv.) and potassium carbonate 
(132 mg, 0.95 mmol, 0.5 equiv.) in acetonitrile (6 mL) with a reaction time of 48 hours at 66 °C 
according to the general procedure. Yield= 62%. Yellow needles, mp= 154-156 °C. 1H-NMR 
[(CD3)2SO] G = 3.17 (s, 3H, NCH3); 4.02 (d, 2H, J = 7.1 Hz, SCH2CH=CH2); 5.15 (d, 1H, J = 10.2 Hz, 
SCH2CH=CH2); 5.40 (d, 1H, J = 17.2 Hz, SCH2CH=CH2); 6.00 (s, 2H, OCH2O); 6.10 (m, 1H, 
SCH2CH=CH2); 6.82 (d, 1H, J = 8.1 Hz, H-5', Ar); 6,83 (s, 1H, C=CH-Ar); 7.37 (dd, 1H, J = 8.1,  
1 Hz, H-6', Ar); 8.05 (s, 1H, H-2', Ar). 13C-NMR [(CD3)2CO] G = 26.51 (NCH3); 33.32 (SCH2); 101.80 
(OCH2O); 108.52 (C-5'); 110.81 (C-2'); 119.51 (CH=CH2); 124.10 (C=CH-Ar); 128.04 (C-6'); 129.03 
(C-1'); 132.01 (CH=CH2); 136.91 (C=CH, C-5); 148.02 (C-4'); 149.21 (C-3'); 163.04 (C=N, C-2); 
169.91 (C=O, C-4). HRMS, m/z found: 302.0723 (calculated for C15H14N2O3S, M
+. requires: 
302.0725). 
(5Z)-5-[(1,3-Benzodioxol-5-yl)methylene]-1-methyl-2-propylthio-1,5-dihydro-4H-imidazol-4-one (6c) : 
The product 6c was prepared from 4a (500 mg, 1.91 mmol), potassium iodide (348 mg, 2.10 mmol, 1.5 
equiv.), 1-bromopropane (5c, 258 mg, 0,19 mL, 2.10 mmol, 1.5 equiv.) and potassium carbonate (132 mg, 
0.95 mmol, 0.5 equiv.) in acetonitrile (6 mL) with a reaction time of 24 hours at 65 °C according to the 
general procedure. Yield= 65%. Yellow needles, mp= 102-104 °C. 1H-NMR [(CD3)2SO] G = 1.11  
(t, 3H, J = 7.4 Hz, CH2CH3); 1.89 (sext, 2H, J = 7.3 Hz, CH2CH3); 3.14 (s, 3H, NCH3); 3.31 (t, 2H,  
J = 7.2 Hz, SCH2); 6.04 (s, 2H, OCH2O); 6.82 (d, 1H, J = 8.1 Hz, H-5', Ar); 6.84 (s, 1H, C=CH); 7.36 
(dd, 1H, J = 8.2, 1.4 Hz, H-6', Ar); 8.05 (d, 1H, J = 1.3 Hz, H-2', Ar). 13C-NMR [(CD3)2CO] G = 13.51 
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(CH2CH3); 22.52 (CH2CH3); 26.50 (NCH3); 32.61 (SCH2); 101.41 (OCH2O); 108.40 (C-5'); 110.82 
(C-2'); 123,.53 (C=CH); 128.04 (C-6'); 129.21 (C-1'); 137.12 (C=CH, C-5); 148.04 (C-4'); 149.03  
(C-3'); 163.81 (C=N, C-2); 169.91 (C=O, C-4). HRMS, m/z found: 304.0861 (calculated for 
C15H16N2O3S, M
+. requires: 304.0882). 
{[(5Z)-5-(1,3-Benzodioxol-5-ylmethylene)-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl]thio} aceto-
nitrile (6d): The product 6c was prepared from 4a (500 mg, 1.91 mmol), chloroacetonitrile (5d, 76 mg, 
63 PL, 1.0 mmol, 1 equiv.) and potassium carbonate (168 mg, 1.0 mmol, 0.5 equiv.) in acetonitrile  
(5 mL) with a reaction time of 19 hours at 81 °C according to the general procedure. Yield= 66%. 
Yellow needles, mp = 211-213 °C. 1H-NMR [(CD3)2SO] G = 3.09 (s, 3H, NCH3); 4,47 (s, 1H, SCH2); 
6.11 (s, 2H, OCH2O); 6.95 (s, 1H, C=CH); 7.00 (d, 1H, J = 8.1 Hz, H-5', Ar); 7,64 (dd, 1H, J = 8.1,  
1.1 Hz, H-6', Ar); 8.11 (d, 1H, J = 1.2 Hz, H-2', Ar). 13C-NMR [(CD3)2CO] G = 16.41 (SCH2); 26.84 
(NCH3); 102.14 (OCH2O); 109.03 (C-5); 110.81 (C-2); 117.34 (CN); 124.71 (C=CH); 128.70(C-1'); 
129.02 (C-6'); 136.51 (C=CH, C-5); 148.20 (C-4'); 149.71 (C-3'); 161.92 (C=N, C-2); 169.04 (C=O, 
C-4). HRMS, m/z found: 301.0507 (calculated for C14H11N3O3S, M
+. requires: 301.0521). 
Ethyl {[(5Z)-5-(1,3-benzodioxol-5-ylmethylene)-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl]thio}- 
acetate (6e): The product 6e was prepared from 4a (200 mg, 0.78 mmol), potassium iodide (193 mg,  
1.16 mmol, 1.5 equiv.), ethyl bromoacetate (5e, 192 mg, 1.16 mmol, 1.1 equiv.) and potassium 
carbonate (54 mg, 0.34 mmol, 0.5 equiv.) in acetonitrile (3 mL) with a reaction time of 14 hours at  
60 °C according to the general procedure. Yield = 68%. Yellow needles, mp = 204-208 °C. 1H-NMR 
[(CD3)2SO] G = 3.14 (s, 3H, NCH3); 1.17 (t, 3H, J = 7.4 Hz, CH2CH3); 2.49 (q, 2H, J = 7.3 Hz, 
CH2CH3); 4.36 (s, 2H, SCH2); 6.13 (s, 2H, OCH2O); 7,13 (d, 1H, J = 8.1 Hz, H-5', Ar); 7.21 (s, 1H,  
J = 1.3 Hz, C=CH); 7.74 (s, 1H, H-2', Ar); 8.13 (dd, 1H, J = 8.1, 1.5 Hz, H-6', Ar). 13C-NMR 
[(CD3)2CO] G = 26.91 (NCH3); 14.22 (CH2CH3); 35.52 (CH2CH3); 62.11 (SCH2); 102.71 (OCH2O); 
109.63 (C-5'); 109.81 (C-2'); 123.80 (C=CH); 127.43 (C-6'); 127.62 (C-1'); 136.44 (C=CH, C-5); 
148.70 (C-4'); 150.43 (C-3'); 167.54 (C=N, C-2); 179.12 (C=O, C-4); 190.83 (C=O). HRMS, m/z 
found: 348.0741 (calculated for C16H16N2O5S, M
+. requires: 348.0780). 
Ethyl {[(5Z)-5-(3,4-dimethoxybenzylidene)-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl]thio}acetate 
(6f): The product 6f was prepared from (5Z)-5-(3,4-dimethoxybenzylidene)-1-methyl-2-
thioxoimidazolidin-4-one (4b, 201 mg, 0.71 mmol), potassium iodide (177 mg, 1.07 mmol, 1.5 
equiv.), ethyl bromoacetate (5e, 178 mg, 1.07 mmol, 1.5 equiv.) and potassium carbonate (49 mg,  
0.36 mmol, 0.5 equiv.) in acetonitrile (3 mL) with a reaction time of 19 hours at 60 °C according to the 
general procedure. Yield= 62%. Yellow needles, mp = 252-254 °C. 1H-NMR [(CD3)2SO] G = 3.14 (s, 
3H, NCH3); 1.21 (t, 3H, J = 7.1 Hz, CH2CH3); 3.81 (s, 3H, OCH3); 3.82 (s, 3H, OCH3); 4.16 (q, 2H,  
J = 7.3 Hz, CH2CH3); 4.35 (s, 2H, SCH2); 7.11 (d, 1H, J = 8.1 Hz, H-5', Ar); 7.18 (s, 1H, C=CH) ; 
7,22 (s, 1H, H-2', Ar); 7.78 (dd, 1H, J = 8.1, 1.4 Hz, H-6', Ar). 13C-NMR [(CD3)2CO] G = 14.22 
(CH2CH3); 26.91 (NCH3); 35.92 (CH2CH3); 55.91 (OCH3); 56.11 (OCH3); 62.13 (SCH2); 112.52  
(C-5'); 113.83 (C-2'); 123,.33 (C=CH); 125.12 (C-6'); 126.10 (C-1'); 136.73 (C=CH, C-5); 149.42  
(C-4'); 151.93 (C-3'); 167.53 (C=N, C-2); 179.14 (C=O, C-4); 190.51 (C=O). HRMS, m/z found: 
364.1086 (calculated for C17H20N2O5S, M
+. requires: 364.1093). 
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(5Z)-5-(1,3-Benzodioxol-5-ylmethylene)-2-[(3-hydroxypropyl)thio]-1-methyl-1,5-dihydro-4H-imidaz-ol-
4-one (6g): The product 6g was prepared from 4a (150 mg, 0.57 mmol), potassium iodide (141 mg, 
0.85 mmol, 1.5 equiv.), 3-bromopropanol (5f, 118 mg, 0.85 mmol, 1.5 equiv.) and potassium 
carbonate (39 mg, 0.28 mmol, 0.5 equiv.) in acetonitrile (4 mL) with a reaction time of 46 hours at  
70 °C according to the general procedure. Yield= 42%. Yellow needles, mp= 256-258 °C. 1H-NMR 
[(CD3)2SO] G = 1.98 (q, 2H, J = 7,4 Hz, CH2CH2OH); 2.03 (t, 2H, J = 7.3 Hz, SCH2); 3.31 (t, 2H,  
J = 7.2 Hz, CH2OH); 6.04 (s, 2H, OCH2O); 6.82 (d, 1H, J = 8,1 Hz, H-5', Ar); 6.84 (s, 1H, J = 1.3 Hz, 
C=CH); 7.36 (s, 1H, H-2', Ar); 8.13 (d, 1H, J = 8,2 Hz; H-6', Ar). 13C-NMR [(CD3)2CO] G = 27.41 
(NCH3); 29.52 (CH2CH2CH2OH); 31.07 (SCH2); 59.11 (CH2OH); 101.42 (OCH2O); 108.13 (C-5'); 
109,8 (C-2); 118.73 (C=CH); 123.93 (C-6'); 126.83 (C-1'); 133.42 (C=CH, C-5); 148.72 (C-4'); 148.83 
(C-3'); 168.52 (C=N, C-2); 177.91 (C=O, C-4). 
4. Conclusions 
In summary, new (5Z)-2-alkylthio-5-arylmethylene-1-methyl-1,5-dihydro-4H-imidazol-4-ones 
bearing two points of diversity have been developed according to a two step protocol. The first step 
involves a solvent-free Knoevenagel condensation under microwave irradiation that produced (5Z)-5-
arylmethylene-2-thioimidazolidin-4-ones in good yields and high purity in a sterecontrolled fashion, 
followed by a chemoselective S-alkylation with retention of double bond configuration. Although a 
limited number of different and representative substituents on the 1-methyl-1,4-dihydro-4H-imidazol-
4-one core are represented here, it's obvious that a much larger diversity can be easily achieved. 
Further studies are currently ongoing. 
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